HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PETA Becomes Revlon Shareholder, Seeking Visibility Into Animal Policies

This article was originally published in The Rose Sheet

Executive Summary

People for the Ethical Treatment of Animals has purchased stock in Revlon, with the intent to issue a shareholder resolution calling for animal-testing transparency. The activist group says other cosmetics firms may be targeted in the future.

You may also be interested in...

Revlon’s Flagship Helps Achieve Q2 Sales Gain; Almay Makeover Ongoing

Second quarter sales at Revlon were up 1.7% on the strength of recent launches including Revlon PhotoReady Airbrush Mousse Makeup and ColorStay Whipped Crème Makeup. Net income totaled $11.1 million, up 70% from the year prior when the firm took a charge of $11.3 million in connection with refinancing of its bank credit facilities.

ICCR Finalizing Nanotech, Trace Impurities Reports Following 6th Meeting

Regulators from the U.S., the EU, Canada and Japan are working to finalize reports on nanomaterials, trace impurities and animal testing alternatives following the sixth meeting of the International Cooperation on Cosmetics Regulation. The regulators came to agreements on the reports at the July 10-13 meeting in Rockville, Md., and will hammer out the details before releasing the reports this fall.

Europe May Reduce Scope Of 2013 Ban On Animal-Tested Cosmetics

The European Commission is considering whether to limit the scope of the 2013 EU ban on cosmetics tested on animals per the Seventh Amendment to the Cosmetics Directive. A decision is expected in the first half of 2012.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts